Shorted

CUV vs IPX — ASX Short Interest Comparison

Side-by-side comparison of short positions for Clinuvel Pharmaceuticals (ASX:CUV) and Iperionx (ASX:IPX), based on official ASIC short position reports as of 25 Sept 2026.

IPX is more heavily shorted, with 12.39% of shares reported as short positions against 8.84% for CUV — a gap of 3.55 percentage points.

CUV

Clinuvel Pharmaceuticals

Short interest
8.84%
Reported positions
4,457,510
Industry
Pharmaceuticals, Biotechnology & Life Sciences

IPX

More shorted

Iperionx

Short interest
12.39%
Reported positions
44,882,548
Industry
Materials

Source: official ASIC short position reports (T+4 delay). Methodology · Disclaimer — not financial advice.